Latest by Barbara Jungwirth

This Week in HIV Research: Erectile Dysfunction in the Modern Age

Reductions in erectile function among men who have sex with men; Australia, San Francisco, and 90-90-90 “fast track” targets; hepatitis C infection and HIV risk; safety of the live herpes zoster vaccine.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Stroke Risk in Less-Studied Populations

Stroke risk among underrepresented populations; the realism of UNAIDS 90-90-90 goals; HIV persistence and inflammation amidst long-term suppression; HDL cholesterol as a predictor of immune recovery.

By Barbara Jungwirth and Myles Helfand

Case Management Improves Linkage to Care for People Living With HIV Post-Release From Prison or Jail, New Study Shows

People living with HIV who spent time in Connecticut correctional facilities and received transitional case management were more likely to be promptly linked to care after their release than those who did not receive such services.

By Barbara Jungwirth

This Week in HIV Research: An Outbreak in West Virginia

How West Virginia is responding; a text-message based continuum-of-care intervention; PrEP and risk compensation; a link between inflammation, frailty, and cytomegalovirus infection.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Why It's Good to Integrate Primary Care With HIV Care

Primary care + HIV care = improved health care engagement; the efficacy of different HIV testing and treatment interventions; abdominal fat and hypertension rates; the ethics of HIV phylogenetics.

By Barbara Jungwirth and Myles Helfand

Insurers and Pharmas Must Help Fix HIV Drug Pricing System, Advocates Say

The Fair Pricing Coalition is working with pharmaceutical companies to ensure fair prices for new HIV drugs on par with those of older medications.

By Barbara Jungwirth

This Week in HIV Research: Can Police Worsen HIV Outbreaks?

Whether a local HIV outbreak in Tijuana, Mexico, may be related to police activity; PrEP and stigma in hookup apps; HIV, aging, and the immune system; cannabis as a systemic anti-inflammatory.

By Barbara Jungwirth and Myles Helfand

More Women Must Be Included in Academia and in Clinical Trials, Panelists Demand

Presentations on women in research at this year's Conference on Retroviruses and Opportunistic Infections highlighted the lack of inclusion, offered ideas on how to remedy the situation, and showed how one woman moved from advocate to researcher.

By Barbara Jungwirth

Long-Term Treated HIV No Defense Against Diabetes Risk

Even in the modern treatment era, HIV-positive men who have sex with men are developing diabetes at an extremely high rate.

By Barbara Jungwirth

This Week in HIV Research: Our High Tally of Glucose Disorders

Long-term glucose disorders; anal vs. cervical HPV; PrEP adherence among U.S. veterans; economic incentives to spur HIV testing.

By Barbara Jungwirth and Myles Helfand